This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Lonza Ag. Active years: 2002-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2008
Title: Kay-Sarah Etter: Innovator in Biochemical Processes
Introduction
Kay-Sarah Etter is a notable inventor based in Niedergampel, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of novel processes for the preparation of amino alcohols and their derivatives. With a total of 3 patents to his name, Etter's work is recognized for its innovative approach and practical applications.
Latest Patents
One of Kay-Sarah Etter's latest patents involves an enzyme for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives. This invention relates to a novel process for creating (1R,4S)- or (1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene and its amino alcohol derivatives. The patent also introduces novel microorganisms capable of utilizing cyclopentene derivatives as their sole nitrogen or carbon source. Another significant patent focuses on the process for the preparation of amino alcohols and their derivatives, along with microorganisms that are useful in this process.
Career Highlights
Kay-Sarah Etter is currently associated with Lonza AG, a leading company in the life sciences sector. His work at Lonza AG has allowed him to explore and develop innovative biochemical processes that have practical applications in various industries.
Collaborations
Etter has collaborated with several professionals in his field, including Christine Bernegger-Egli and Olwen M Birch. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Kay-Sarah Etter's contributions to biochemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new biochemical processes and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
